Colorectal cancer biology, diagnosis, and therapeutic approaches

B Dariya, S Aliya, N Merchant, A Alam… - Critical Reviews™ in …, 2020 - dl.begellhouse.com
Colorectal cancer (CRC) is the second most diagnosed disease worldwide. It is the fourth
leading cause of cancer related mortalities. Higher probability for the occurrence of CRC is …

The roadmap of colorectal cancer screening

E Ferlizza, R Solmi, M Sgarzi, L Ricciardiello… - Cancers, 2021 - mdpi.com
Simple Summary Colorectal cancer (CRC) is the third most common form of cancer in terms
of incidence and the second in terms of mortality worldwide. CRC develops over several …

Clinical significance and diagnostic value of serum NSE, CEA, CA19‑9, CA125 and CA242 levels in colorectal cancer

H Luo, K Shen, B Li, R Li, Z Wang… - Oncology …, 2020 - spandidos-publications.com
The present study investigated the value of combinations of five specific tumor biomarkers
for the diagnosis of colorectal cancer (CRC): Neuron‑specific enolase (NSE) …

Colorectal cancers in low-and middle-income countries—demographic pattern and clinical profile of 970 patients treated at a tertiary care cancer center in India

SVS Deo, S Kumar, S Bhoriwal, NK Shukla… - JCO global …, 2021 - ascopubs.org
PURPOSE Globally, colorectal cancer (CRC) ranks third in terms of incidence and second in
terms of mortality. A relatively low burden of CRC has been reported from low-and middle …

Trajectories of perioperative serum tumor markers and colorectal cancer outcomes: A retrospective, multicenter longitudinal cohort study

C Li, D Zhang, X Pang, H Pu, M Lei, B Fan, J Lv… - …, 2021 - thelancet.com
Background The dynamic monitoring of perioperative carcinoembryonic antigen (CEA) is
recommended by current colorectal cancer (CRC) guidelines, while the benefits of …

Prediction models of colorectal cancer prognosis incorporating perioperative longitudinal serum tumor markers: a retrospective longitudinal cohort study

C Li, K Zhao, D Zhang, X Pang, H Pu, M Lei, B Fan… - BMC medicine, 2023 - Springer
Background Current prognostic prediction models of colorectal cancer (CRC) include only
the preoperative measurement of tumor markers, with their available repeated postoperative …

Brain metastases from colorectal cancer: a systematic review of the literature and meta-analysis to establish a guideline for daily treatment

S Müller, F Köhler, A Hendricks, C Kastner, K Börner… - Cancers, 2021 - mdpi.com
Simple Summary Brain metastases (BM) from colorectal cancer (CRC) are rare. There is
little available information regarding incidence, risk factors, prognostic factors, treatment …

Personalized medicine—current and emerging predictive and prognostic biomarkers in colorectal cancer

C Koulis, R Yap, R Engel, T Jardé, S Wilkins, G Solon… - Cancers, 2020 - mdpi.com
Colorectal cancer (CRC) is the third most common cancer diagnosed worldwide and is
heterogeneous both morphologically and molecularly. In an era of personalized medicine …

An elevated CA 19-9 is associated with invasive cancer and worse survival in IPMN

D Ciprani, V Morales-Oyarvide, M Qadan, T Hank… - Pancreatology, 2020 - Elsevier
Background Current guidelines for IPMN include an elevated serum carbohydrate antigen
(CA) 19-9 among the worrisome features. However, the correlation of CA 19-9 with …

Humoral predictors of malignancy in IPMN: a review of the literature

EC Nista, T Schepis, M Candelli, L Giuli… - International Journal of …, 2021 - mdpi.com
Pancreatic cystic lesions are increasingly detected in cross-sectional imaging. Intraductal
papillary mucinous neoplasm (IPMN) is a mucin-producing subtype of the pancreatic cyst …